Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms

The study is devoted to the study of acute toxicity of a new quinazoline compound — 3-[2-Oxo-2-(4-phenylpiperazine-1-yl)ethyl]quinazoline-4(3H)-one (VMA-10-21), promising as an antimicrobial agent active against opportunistic microorganisms. Purpose. Assessment of acute toxicity of the quinazoline d...

Full description

Saved in:
Bibliographic Details
Main Authors: N. M. Gabitova, A. A. Tsibizova, A. A. Ozerov, M. A. Samotrueva
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2023-07-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/1016
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403814418841600
author N. M. Gabitova
A. A. Tsibizova
A. A. Ozerov
M. A. Samotrueva
author_facet N. M. Gabitova
A. A. Tsibizova
A. A. Ozerov
M. A. Samotrueva
author_sort N. M. Gabitova
collection DOAJ
description The study is devoted to the study of acute toxicity of a new quinazoline compound — 3-[2-Oxo-2-(4-phenylpiperazine-1-yl)ethyl]quinazoline-4(3H)-one (VMA-10-21), promising as an antimicrobial agent active against opportunistic microorganisms. Purpose. Assessment of acute toxicity of the quinazoline derivative 3-[2-oxo-2-(4-phenylpiperazine-1yl)ethyl] quinazoline-4(3h)-oh, exhibiting antimicrobial activity. Material and methods. All experiments were carried out on non-linear mature female rats with a body weight of 180–190 g. Female individuals were in the diestrus stage. The rats were divided into groups (n=6) by a random sample, there were 4 individuals in each group and were kept in cages for a week before the experiment, getting used to laboratory conditions: animals receiving intragastric equiobjection of distilled water (control); experimental animals treated with the compound VMA-10-21 at doses of 1000, 2000; 5000 mg/kg (the doses were selected based on the fact that the study of the toxicity of pyrimidine derivatives with a similar chemical structure showed their relative safety and the absence of lethality from a dose of 500 mg/kg). Results. Assessment of acute toxicity of the quinazoline derivative 3-[2-oxo-2-(4-phenylpiperazine-1yl)ethyl]quinazoline-4(3h)-oh with intragastric administration showed that this compound belongs to class 5 toxicity and is low-toxic according to. Under these conditions, and for LD₅₀, the maximum dose is 5000 mg/kg. However, despite the results obtained, when this compound was administered at a dose of 5000 mg/kg, changes in hemoglobin, the number of leukocytes and platelets, as well as total protein were observed, which may indicate the possible development of pathological changes in the hematopoietic and hepatobiliary systems. Conclusion. Thus, the quinazoline derivative 3-[2-oxo-2-(4-phenylpiperazine-1yl)ethyl]quinazoline-4(3h)-oh with intragastric administration is low-toxic and belongs to the 5th class of toxicity, and therefore the maximum dose is 5000 mg/kg for LD₅₀. However, given the fact that there are changes in hematological and biochemical parameters, this compound needs to be studied in detail under the conditions of course effects on the body of animals.
format Article
id doaj-art-30828dba1fc341fe88689d4dc50a8e94
institution Kabale University
issn 0235-2990
language Russian
publishDate 2023-07-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-30828dba1fc341fe88689d4dc50a8e942025-08-20T03:37:10ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902023-07-01683-4303410.37489/0235-2990-2023-68-3-4-30-34950Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic MicroorganismsN. M. Gabitova0A. A. Tsibizova1A. A. Ozerov2M. A. Samotrueva3Astrakhan State Medical University of the Ministry of Health of the Russian FederationAstrakhan State Medical University of the Ministry of Health of the Russian FederationVolgograd State Medical University of the Ministry of Health of the Russian FederationAstrakhan State Medical University of the Ministry of Health of the Russian FederationThe study is devoted to the study of acute toxicity of a new quinazoline compound — 3-[2-Oxo-2-(4-phenylpiperazine-1-yl)ethyl]quinazoline-4(3H)-one (VMA-10-21), promising as an antimicrobial agent active against opportunistic microorganisms. Purpose. Assessment of acute toxicity of the quinazoline derivative 3-[2-oxo-2-(4-phenylpiperazine-1yl)ethyl] quinazoline-4(3h)-oh, exhibiting antimicrobial activity. Material and methods. All experiments were carried out on non-linear mature female rats with a body weight of 180–190 g. Female individuals were in the diestrus stage. The rats were divided into groups (n=6) by a random sample, there were 4 individuals in each group and were kept in cages for a week before the experiment, getting used to laboratory conditions: animals receiving intragastric equiobjection of distilled water (control); experimental animals treated with the compound VMA-10-21 at doses of 1000, 2000; 5000 mg/kg (the doses were selected based on the fact that the study of the toxicity of pyrimidine derivatives with a similar chemical structure showed their relative safety and the absence of lethality from a dose of 500 mg/kg). Results. Assessment of acute toxicity of the quinazoline derivative 3-[2-oxo-2-(4-phenylpiperazine-1yl)ethyl]quinazoline-4(3h)-oh with intragastric administration showed that this compound belongs to class 5 toxicity and is low-toxic according to. Under these conditions, and for LD₅₀, the maximum dose is 5000 mg/kg. However, despite the results obtained, when this compound was administered at a dose of 5000 mg/kg, changes in hemoglobin, the number of leukocytes and platelets, as well as total protein were observed, which may indicate the possible development of pathological changes in the hematopoietic and hepatobiliary systems. Conclusion. Thus, the quinazoline derivative 3-[2-oxo-2-(4-phenylpiperazine-1yl)ethyl]quinazoline-4(3h)-oh with intragastric administration is low-toxic and belongs to the 5th class of toxicity, and therefore the maximum dose is 5000 mg/kg for LD₅₀. However, given the fact that there are changes in hematological and biochemical parameters, this compound needs to be studied in detail under the conditions of course effects on the body of animals.https://www.antibiotics-chemotherapy.ru/jour/article/view/1016quinazoline derivativesacute toxicityhematological parametersbiochemical parameters
spellingShingle N. M. Gabitova
A. A. Tsibizova
A. A. Ozerov
M. A. Samotrueva
Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
Антибиотики и Химиотерапия
quinazoline derivatives
acute toxicity
hematological parameters
biochemical parameters
title Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
title_full Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
title_fullStr Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
title_full_unstemmed Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
title_short Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
title_sort assessment of acute toxicity of quinazoline derivative 3 2 oxo 2 4 phenylpiperazine 1 yl ethyl quinazoline 4 3h oh active against opportunistic microorganisms
topic quinazoline derivatives
acute toxicity
hematological parameters
biochemical parameters
url https://www.antibiotics-chemotherapy.ru/jour/article/view/1016
work_keys_str_mv AT nmgabitova assessmentofacutetoxicityofquinazolinederivative32oxo24phenylpiperazine1ylethylquinazoline43hohactiveagainstopportunisticmicroorganisms
AT aatsibizova assessmentofacutetoxicityofquinazolinederivative32oxo24phenylpiperazine1ylethylquinazoline43hohactiveagainstopportunisticmicroorganisms
AT aaozerov assessmentofacutetoxicityofquinazolinederivative32oxo24phenylpiperazine1ylethylquinazoline43hohactiveagainstopportunisticmicroorganisms
AT masamotrueva assessmentofacutetoxicityofquinazolinederivative32oxo24phenylpiperazine1ylethylquinazoline43hohactiveagainstopportunisticmicroorganisms